Breast Cancer Clinical Trial
Official title:
Long Term Impact of a Physical Activity Intervention Combining Workshop During a Balneotherapy and a Web and Smartphone-based Physical Activity Program After Balneotherapy, on Physical Activity Level : a Randomized Control Trial
The purpose of this study is to evaluate the impact of an intervention combining a workshop
during a balneotherapy and the use after the end of the balneotherapy of a web and
smartphone-based physical activity program using connected devices, on physical activity
level among patients 12 months after they participated in a balneotherapy in thermal care
center.
A multi center randomized controlled trial is setting to evaluate the impact of the
intervention on physical activity recommendations achievement of the patients.
Investigators hypothesize that an intervention including a workshop during a balneotherapy
and an automated physical activity program using web, mobile phone and connected devices will
help patients to be engaged in more physical activities and to reach physical activity
recommendations.
New technologies such as mobile phone and connected devices have been recognized as useful
tools to assist chronic patients in their disease's management. they are also considering as
promising tools to help patients to change their lifestyle behavior.
Balneotherapy is a very special moment to initiate changes and to raise awareness about
healthier behavior in terms of food and physical activity.
The objective of the intervention is to help patients with chronic diseases, taking part in a
balneotherapy, to increase or maintain their physical activity level in the long term to
reach the national recommendations of 150 minutes of moderate physical activity per week.
Patients will be randomized either in the intervention group or in the control group.
The intervention group will participate in a workshop during the balneotherapy providing them
informations about physical activity and also about the way to use the web and
smartphone-based physical activity program along with the use of the connected devices (scale
and pedometer). After the end of the balneotherapy, the intervention group will have access
to the web and smartphone-based physical activity program during 12 months.
The control group will receive a booklet including informations about physical activity
practice.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03095352 -
A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
|
||
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Active, not recruiting |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Recruiting |
NCT03412877 -
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in People With Metastatic Cancer
|
Phase 2 | |
| Recruiting |
NCT03709134 -
Genomic Markers for Measuring Metastatic Risk in Breast Cancer Following Primary Treatment
|
||
| Recruiting |
NCT03667716 -
COM701 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT02894398 -
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
|
Phase 2 | |
| Active, not recruiting |
NCT01857193 -
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Recruiting |
NCT03432429 -
REI-EXCISE iKnife Study
|
N/A | |
| Active, not recruiting |
NCT02139358 -
Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03615573 -
Survey Study: Financial Impact of Breast Cancer Treatment
|
||
| Completed |
NCT03323333 -
Psychosocial Intervention Pilot for Partners in BRCA Testing
|
N/A | |
| Terminated |
NCT01649258 -
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
|
Phase 1 | |
| Withdrawn |
NCT03285607 -
MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer
|
Phase 1 | |
| Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
| Recruiting |
NCT01992432 -
Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)
|
||
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |
